State-of-the-Art Sessions Tuesday
Tuesday, July 2, 11.00-12.00
SoA-07: Common and rare bleeding disorders, global aspects
- Translational medicine advances in Von Willebrand Disease
David Lillicrap (Canada) - Future of coagulation factor replacement therapy
Flora Peyvandi (Italy)
SoA-08: Venous thrombosis
- Optimal treatment duration of venous thrombosis
Walter Ageno (Italy) - Venous thrombosis: understanding the paradoxes of recurrence
Suzanne Cannegieter (Netherlands)
SoA-09: Pro-coagulant and anti-coagulant mechanisms
- Key molecular and cellular players in venous thrombosis
Steffen Massberg (Germany) - Mechanisms of anticoagulant and cytoprotective actions
Laurent Mosnier (USA)
SoA-10: Platelets
- Antiplatelet therapy: new pharmacological agents and changing paradigms
Dominick Angiolillo (USA) - Platelet glycoproteins with platelet-activating property, GPVI, GPIb/IX-V and CLEC-2
Yukio Ozaki (Japan)
SoA-11: Structure function coagulation proteins
- Thrombin inhibition by the serpins
James Huntington (United Kingdom) - The transition of prothrombin to thrombin
Sriram Krishnaswami (USA)
SoA-12: Biology of ADAMTS13
- Animal models for thrombotic thrombocytopenic purpura
Karen Vanhoorelbeke (Belgium)
Structure-function and cofactor-dependent regulation of ADAMTS13
X. Long Zheng (USA)